News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
732,561 Results
Type
Article (41433)
Company Profile (263)
Press Release (690852)
Multimedia
Podcasts (94)
Webinars (20)
Section
Business (204877)
Career Advice (2033)
Deals (35602)
Drug Delivery (132)
Drug Development (81559)
Employer Resources (173)
FDA (16520)
Job Trends (14991)
News (346911)
Policy (32750)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2603)
Accelerated approval (53)
Adcomms (27)
Allergies (176)
Alliances (49581)
ALS (218)
Alzheimer's disease (1810)
Antibody-drug conjugate (ADC) (488)
Approvals (16940)
Artificial intelligence (688)
Autoimmune disease (315)
Automation (58)
Bankruptcy (362)
Best Places to Work (11635)
BIOSECURE Act (20)
Biosimilars (227)
Biotechnology (170)
Bladder cancer (200)
Brain cancer (73)
Breast cancer (783)
Cancer (6089)
Cardiovascular disease (485)
Career advice (1728)
Career pathing (44)
CAR-T (345)
CDC (57)
Celiac Disease (3)
Cell therapy (930)
Cervical cancer (51)
Clinical research (71165)
Collaboration (2117)
Company closure (5)
Compensation (1437)
Complete response letters (82)
COVID-19 (2749)
CRISPR (111)
C-suite (1169)
Cystic fibrosis (154)
Data (8304)
Decentralized trials (3)
Denatured (28)
Depression (164)
Dermatology (93)
Diabetes (612)
Diagnostics (6984)
Digital health (58)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (332)
Drug pricing (201)
Drug shortages (31)
Duchenne muscular dystrophy (292)
Earnings (92166)
Editorial (66)
Employer branding (21)
Employer resources (152)
Events (120149)
Executive appointments (1097)
FDA (20359)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1770)
Gene editing (238)
Generative AI (58)
Gene therapy (732)
GLP-1 (1062)
Government (4740)
Grass and pollen (6)
Guidances (414)
Healthcare (19119)
HIV (82)
Huntington's disease (57)
IgA nephropathy (106)
Immunology and inflammation (291)
Immuno-oncology (99)
Indications (200)
Infectious disease (3103)
Inflammatory bowel disease (216)
Inflation Reduction Act (14)
Influenza (137)
Intellectual property (301)
Interviews (320)
IPO (16670)
IRA (50)
Job creations (3649)
Job search strategy (1431)
JPM (58)
Kidney cancer (20)
Labor market (107)
Layoffs (567)
Leadership (40)
Legal (7953)
Liver cancer (102)
Longevity (33)
Lung cancer (814)
Lymphoma (448)
Machine learning (60)
Management (59)
Manufacturing (1085)
MASH (200)
Medical device (13954)
Medtech (14093)
Mergers & acquisitions (20196)
Metabolic disorders (1553)
mRNA (217)
Multiple sclerosis (193)
NASH (17)
Neurodegenerative disease (435)
Neuropsychiatric disorders (106)
Neuroscience (3374)
Neurotech (1)
NextGen: Class of 2026 (6522)
Non-profit (4533)
Now hiring (79)
Obesity (719)
Opinion (289)
Ovarian cancer (233)
Pain (258)
Pancreatic cancer (326)
Parkinson's disease (377)
Partnered (33)
Patents (610)
Patient recruitment (696)
Peanut (64)
People (59708)
Pharmaceutical (58)
Pharmacy benefit managers (33)
Phase 1 (22192)
Phase 2 (31354)
Phase 3 (23324)
Pipeline (9276)
Policy (322)
Postmarket research (2569)
Preclinical (9435)
Press Release (64)
Prostate cancer (322)
Psychedelics (54)
Radiopharmaceuticals (337)
Rare diseases (1106)
Real estate (5973)
Recruiting (70)
Regulatory (25564)
Reports (56)
Research institute (2417)
Resumes & cover letters (354)
Rett syndrome (39)
RNA editing (23)
RSV (88)
Schizophrenia (179)
Series A (297)
Series B (217)
Service/supplier (11)
Sickle cell disease (117)
Special edition (24)
Spinal muscular atrophy (167)
Sponsored (48)
Startups (3644)
State (2)
Stomach cancer (18)
Supply chain (130)
Tariffs (87)
The Weekly (64)
Vaccines (1119)
Venture capital (114)
Weight loss (459)
Women's health (130)
Worklife (20)
Date
Today (151)
Last 7 days (754)
Last 30 days (3363)
Last 365 days (30272)
2026 (14322)
2025 (30168)
2024 (35209)
2023 (40072)
2022 (51173)
2021 (55706)
2020 (54080)
2019 (46535)
2018 (35015)
2017 (32106)
2016 (31479)
2015 (37551)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (741)
Alabama (93)
Alaska (7)
Arizona (354)
Arkansas (14)
Asia (39793)
Australia (6526)
California (13651)
Canada (3853)
China (1414)
Colorado (580)
Connecticut (597)
Delaware (421)
Europe (86120)
Florida (2039)
Georgia (438)
Hawaii (3)
Idaho (63)
Illinois (1101)
India (92)
Indiana (617)
Iowa (23)
Japan (560)
Kansas (132)
Kentucky (50)
Louisiana (44)
Maine (76)
Maryland (1633)
Massachusetts (9752)
Michigan (370)
Minnesota (737)
Mississippi (6)
Missouri (146)
Montana (33)
Nebraska (29)
Nevada (145)
New Hampshire (84)
New Jersey (3573)
New Mexico (30)
New York (3574)
North Carolina (1723)
North Dakota (9)
Northern California (6871)
Ohio (408)
Oklahoma (23)
Oregon (41)
Pennsylvania (2735)
Puerto Rico (29)
Rhode Island (51)
South America (1112)
South Carolina (86)
South Dakota (2)
Southern California (5401)
Tennessee (216)
Texas (2171)
United States (48098)
Utah (405)
Vermont (1)
Virginia (329)
Washington D.C. (81)
Washington State (1090)
West Virginia (4)
Wisconsin (129)
Wyoming (2)
732,561 Results for "omniseq inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Crescita Therapeutics Inc. Announces Closing of Arrangement
June 4, 2026
·
3 min read
Press Releases
NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
June 3, 2026
·
4 min read
Press Releases
NRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
June 3, 2026
·
5 min read
Press Releases
SGS Expands Bioanalytical Testing Capabilities in North America with Acquisition of CMIC, INC.
June 4, 2026
·
3 min read
Press Releases
OrthAlign, Inc. Receives FDA 510(k) clearance for the Lantern® ASC system
June 3, 2026
·
3 min read
Press Releases
Celcuity Inc. Announces Public Offering of Convertible Senior Notes Due 2032
June 3, 2026
·
8 min read
Press Releases
Metagenomi Therapeutics, Inc. to Present at the 2026 Jefferies Global Healthcare Conference
May 28, 2026
·
1 min read
Policy
OmniSeq Receives New York State Approval for OmniSeq INSIGHT Genomic and Immune Profiling Test
OmniSeq®, an innovator in next generation sequencing in oncology, announced the New York State Department of Health’s Clinical Laboratory Evaluation Program has approved the OmniSeq INSIGHTSM test.
April 28, 2021
·
3 min read
Press Releases
Stonegate Initiates Coverage on StimCell Energetics Inc. (STME)
May 15, 2026
·
1 min read
Press Releases
RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum
May 20, 2026
·
1 min read
1 of 73,257
Next
